Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 27 | $51,596,655 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Sep 2024 21:20 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 20 Sep 2024 | Sale | 200 | 71.985 | 14,397 | D |
20 Sep 2024 21:20 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 20 Sep 2024 | Sale | 119,874 | 71.1501 | 8,529,047 | D |
20 Sep 2024 21:20 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 20 Sep 2024 | Sale | 96,056 | 70.4288 | 6,765,109 | D |
22 Aug 2024 19:23 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 21 Aug 2024 | Sale | 1,000 | 69.9 | 69,900 | D |
19 Aug 2024 20:13 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 19 Aug 2024 | Sale | 11,296 | 67.1206 | 758,194 | D |
19 Aug 2024 20:13 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 19 Aug 2024 | Sale | 31,442 | 66.3705 | 2,086,821 | D |
19 Aug 2024 20:13 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 19 Aug 2024 | Sale | 70,132 | 65.3267 | 4,581,492 | D |
31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Jul 2024 | Sale | 30,417 | 58.78 | 1,787,911 | D |
31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Jul 2024 | Sale | 19,501 | 57.81 | 1,127,353 | D |
31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Jul 2024 | Sale | 65,941 | 56.95 | 3,755,340 | D |
09 Feb 2024 20:59 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 09 Feb 2024 | Sale | 45,000 | 29.9 | 1,345,500 | D |
08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 40,000 | 28.9 | 1,156,000 | D |
08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 40,000 | 27.45 | 1,098,000 | D |
08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 80,000 | 26.95 | 2,156,000 | D |
08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 60,000 | 25.95 | 1,557,000 | D |
08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 49,079 | 25.75 | 1,263,784 | D |
31 Jan 2024 20:39 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 31 Jan 2024 | Sale | 40,000 | 24.45 | 978,000 | D |
31 Jan 2024 20:39 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 31 Jan 2024 | Sale | 45,000 | 24.95 | 1,122,750 | D |
30 Jan 2024 21:05 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Jan 2024 | Sale | 35,000 | 23.95 | 838,250 | D |
01 May 2023 19:03 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 01 May 2023 | Sale | 45,000 | 22.45 | 1,010,250 | D |
21 Apr 2023 19:29 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 19 Apr 2023 | Sale | 35,000 | 21.45 | 750,750 | D |
18 Apr 2023 19:09 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 17 Apr 2023 | Sale | 155,000 | 20.4501 | 3,169,766 | D |
13 Apr 2023 17:14 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 13 Apr 2023 | Sale | 79,336 | 18.45 | 1,463,749 | D |
03 Apr 2023 19:26 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 03 Apr 2023 | Sale | 22,000 | 17.85 | 392,700 | D |
03 Apr 2023 19:26 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 31 Mar 2023 | Sale | 67,970 | 17.45 | 1,186,076 | D |
03 Apr 2023 19:26 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Mar 2023 | Sale | 65,382 | 17.45 | 1,140,916 | D |
03 Apr 2023 19:26 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Mar 2023 | Sale | 88,000 | 16.95 | 1,491,600 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)